Jana ChisholmFeb 83 minEyes on BioPharma Portfolio StrategiesThis week we've had Eyes how BioPharma are bolstering their Portfolios for long-term success. From licensing assets ...
Robin BatemanMay 15, 20222 minProduct Approvals, Delays & DisappointmentsThis was a busy week for Healthcare with 1Q22 Results. The PharmaTell Team had eyes on some of the US FDA decisions + Roche's SKYSCRAPER-01